An alumnus of Suffolk University, Nicholas “Nick” Boulas guides Nick's Painting Services, Inc. and oversees all aspects of the firm’s business operations, such as customer service, sales, marketing, and finance. Actively involved in running and philanthropy, Nick Boulas has participated in the Boston Marathon several times on behalf of the Claudia Barr program at the Dana Farber Cancer Institute.
Dana-Farber is dedicated to delivering the finest cancer treatment while developing novel therapies via its dedicated cancer institute's rigorous research. Prostate Cancer Foundation (PCF) Challenge Award has been given to Dana-Farber Cancer Institute researchers. The $1 million prize is intended to promote their study, which may lead to the development of novel therapies for metastatic prostate cancer. The primary investigator is Matthew Freedman, MD, of the Dana-Farber Cancer Institute.
Prostate cancer that has advanced to a metastatic, treatment-resistant stage presently has no curative therapeutic options. Freedman and his colleagues discovered a collection of gene transcription regulators that regulate this process. If the regulators can design novel therapies to stop prostate cancer from progressing to advanced, fatal stages. The team is also working on a prostate cancer research resource that will aid other researchers in discovering new therapy options for prostate cancer patients.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.